HEADER PROTEIN TRANSPORT 23-JUL-15 5CRU TITLE CRYSTAL STRUCTURE OF THE BRO DOMAIN OF HD-PTP COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 23; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 1-361; COMPND 5 SYNONYM: HD-PTP,HIS DOMAIN-CONTAINING PROTEIN TYROSINE PHOSPHATASE, COMPND 6 PROTEIN TYROSINE PHOSPHATASE TD14,PTP-TD14; COMPND 7 EC: 3.1.3.48; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN23, KIAA1471; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HD-PTP, BRO DOMAIN, EGFR, PTP, PROTEIN TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR J.LEE,B.KU,S.J.KIM REVDAT 2 08-NOV-23 5CRU 1 REMARK REVDAT 1 24-FEB-16 5CRU 0 JRNL AUTH J.LEE,K.-J.OH,D.LEE,B.Y.KIM,J.S.CHOI,B.KU,S.J.KIM JRNL TITL STRUCTURAL STUDY OF THE HD-PTP BRO1 DOMAIN IN A COMPLEX WITH JRNL TITL 2 THE CORE REGION OF STAM2, A SUBUNIT OF ESCRT-0 JRNL REF PLOS ONE V. 11 49113 2016 JRNL REFN ESSN 1932-6203 JRNL PMID 26866605 JRNL DOI 10.1371/JOURNAL.PONE.0149113 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.060 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 3 NUMBER OF REFLECTIONS : 50947 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.940 REMARK 3 FREE R VALUE TEST SET COUNT : 2007 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.9778 - 5.7727 0.97 3629 144 0.1711 0.2292 REMARK 3 2 5.7727 - 4.5868 0.99 3681 154 0.1943 0.2421 REMARK 3 3 4.5868 - 4.0084 0.98 3661 144 0.1823 0.1984 REMARK 3 4 4.0084 - 3.6425 0.99 3652 154 0.2096 0.2311 REMARK 3 5 3.6425 - 3.3818 0.99 3697 135 0.2286 0.2691 REMARK 3 6 3.3818 - 3.1826 0.98 3639 158 0.2386 0.2650 REMARK 3 7 3.1826 - 3.0233 0.97 3604 161 0.2598 0.2725 REMARK 3 8 3.0233 - 2.8918 0.95 3531 144 0.2730 0.3630 REMARK 3 9 2.8918 - 2.7806 0.92 3408 139 0.2601 0.3157 REMARK 3 10 2.7806 - 2.6847 0.91 3432 140 0.2655 0.2987 REMARK 3 11 2.6847 - 2.6008 0.91 3363 134 0.2650 0.3028 REMARK 3 12 2.6008 - 2.5265 0.88 3268 132 0.2626 0.3440 REMARK 3 13 2.5265 - 2.4600 0.87 3233 141 0.2716 0.3108 REMARK 3 14 2.4600 - 2.4000 0.85 3142 127 0.2932 0.3439 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.540 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 11616 REMARK 3 ANGLE : 1.012 15690 REMARK 3 CHIRALITY : 0.038 1702 REMARK 3 PLANARITY : 0.006 2039 REMARK 3 DIHEDRAL : 15.082 4392 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5CRU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000212089. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 5C (4A) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55835 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3RAU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.03 M HEPES SODIUM, 16%(W/V) REMARK 280 POLYETHYLENE GLYCOL 3350, 0.67%(W/V) TRYPTONE, 0.03 M UREA, PH REMARK 280 7.3, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 361 REMARK 465 ALA B 358 REMARK 465 LYS B 359 REMARK 465 LEU B 360 REMARK 465 VAL B 361 REMARK 465 VAL C 361 REMARK 465 ALA D 358 REMARK 465 LYS D 359 REMARK 465 LEU D 360 REMARK 465 VAL D 361 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 27 OD1 ASN A 42 2.02 REMARK 500 OE1 GLU C 98 OG SER C 101 2.05 REMARK 500 NH1 ARG D 219 OE2 GLU D 222 2.06 REMARK 500 NZ LYS C 27 OD1 ASN C 42 2.11 REMARK 500 OD1 ASN C 33 NH1 ARG D 205 2.14 REMARK 500 NZ LYS C 27 O PRO C 38 2.16 REMARK 500 OE2 GLU B 108 O HOH B 401 2.19 REMARK 500 O VAL D 4 NH2 ARG D 6 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 137 NZ LYS C 215 1564 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLN C 290 CA - CB - CG ANGL. DEV. = 16.8 DEGREES REMARK 500 PRO D 332 C - N - CA ANGL. DEV. = 10.4 DEGREES REMARK 500 PRO D 332 C - N - CD ANGL. DEV. = -12.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 36 -157.85 -123.88 REMARK 500 LEU B 330 145.88 -39.72 REMARK 500 GLN D 163 107.31 -36.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU B 330 GLN B 331 147.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 411 DISTANCE = 7.10 ANGSTROMS REMARK 525 HOH D 409 DISTANCE = 5.94 ANGSTROMS REMARK 525 HOH D 410 DISTANCE = 7.10 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5CRV RELATED DB: PDB DBREF 5CRU A 1 361 UNP Q9H3S7 PTN23_HUMAN 1 361 DBREF 5CRU B 1 361 UNP Q9H3S7 PTN23_HUMAN 1 361 DBREF 5CRU C 1 361 UNP Q9H3S7 PTN23_HUMAN 1 361 DBREF 5CRU D 1 361 UNP Q9H3S7 PTN23_HUMAN 1 361 SEQRES 1 A 361 MET GLU ALA VAL PRO ARG MET PRO MET ILE TRP LEU ASP SEQRES 2 A 361 LEU LYS GLU ALA GLY ASP PHE HIS PHE GLN PRO ALA VAL SEQRES 3 A 361 LYS LYS PHE VAL LEU LYS ASN TYR GLY GLU ASN PRO GLU SEQRES 4 A 361 ALA TYR ASN GLU GLU LEU LYS LYS LEU GLU LEU LEU ARG SEQRES 5 A 361 GLN ASN ALA VAL ARG VAL PRO ARG ASP PHE GLU GLY CYS SEQRES 6 A 361 SER VAL LEU ARG LYS TYR LEU GLY GLN LEU HIS TYR LEU SEQRES 7 A 361 GLN SER ARG VAL PRO MET GLY SER GLY GLN GLU ALA ALA SEQRES 8 A 361 VAL PRO VAL THR TRP THR GLU ILE PHE SER GLY LYS SER SEQRES 9 A 361 VAL ALA HIS GLU ASP ILE LYS TYR GLU GLN ALA CYS ILE SEQRES 10 A 361 LEU TYR ASN LEU GLY ALA LEU HIS SER MET LEU GLY ALA SEQRES 11 A 361 MET ASP LYS ARG VAL SER GLU GLU GLY MET LYS VAL SER SEQRES 12 A 361 CYS THR HIS PHE GLN CYS ALA ALA GLY ALA PHE ALA TYR SEQRES 13 A 361 LEU ARG GLU HIS PHE PRO GLN ALA TYR SER VAL ASP MET SEQRES 14 A 361 SER ARG GLN ILE LEU THR LEU ASN VAL ASN LEU MET LEU SEQRES 15 A 361 GLY GLN ALA GLN GLU CYS LEU LEU GLU LYS SER MET LEU SEQRES 16 A 361 ASP ASN ARG LYS SER PHE LEU VAL ALA ARG ILE SER ALA SEQRES 17 A 361 GLN VAL VAL ASP TYR TYR LYS GLU ALA CYS ARG ALA LEU SEQRES 18 A 361 GLU ASN PRO ASP THR ALA SER LEU LEU GLY ARG ILE GLN SEQRES 19 A 361 LYS ASP TRP LYS LYS LEU VAL GLN MET LYS ILE TYR TYR SEQRES 20 A 361 PHE ALA ALA VAL ALA HIS LEU HIS MET GLY LYS GLN ALA SEQRES 21 A 361 GLU GLU GLN GLN LYS PHE GLY GLU ARG VAL ALA TYR PHE SEQRES 22 A 361 GLN SER ALA LEU ASP LYS LEU ASN GLU ALA ILE LYS LEU SEQRES 23 A 361 ALA LYS GLY GLN PRO ASP THR VAL GLN ASP ALA LEU ARG SEQRES 24 A 361 PHE THR MET ASP VAL ILE GLY GLY LYS TYR ASN SER ALA SEQRES 25 A 361 LYS LYS ASP ASN ASP PHE ILE TYR HIS GLU ALA VAL PRO SEQRES 26 A 361 ALA LEU ASP THR LEU GLN PRO VAL LYS GLY ALA PRO LEU SEQRES 27 A 361 VAL LYS PRO LEU PRO VAL ASN PRO THR ASP PRO ALA VAL SEQRES 28 A 361 THR GLY PRO ASP ILE PHE ALA LYS LEU VAL SEQRES 1 B 361 MET GLU ALA VAL PRO ARG MET PRO MET ILE TRP LEU ASP SEQRES 2 B 361 LEU LYS GLU ALA GLY ASP PHE HIS PHE GLN PRO ALA VAL SEQRES 3 B 361 LYS LYS PHE VAL LEU LYS ASN TYR GLY GLU ASN PRO GLU SEQRES 4 B 361 ALA TYR ASN GLU GLU LEU LYS LYS LEU GLU LEU LEU ARG SEQRES 5 B 361 GLN ASN ALA VAL ARG VAL PRO ARG ASP PHE GLU GLY CYS SEQRES 6 B 361 SER VAL LEU ARG LYS TYR LEU GLY GLN LEU HIS TYR LEU SEQRES 7 B 361 GLN SER ARG VAL PRO MET GLY SER GLY GLN GLU ALA ALA SEQRES 8 B 361 VAL PRO VAL THR TRP THR GLU ILE PHE SER GLY LYS SER SEQRES 9 B 361 VAL ALA HIS GLU ASP ILE LYS TYR GLU GLN ALA CYS ILE SEQRES 10 B 361 LEU TYR ASN LEU GLY ALA LEU HIS SER MET LEU GLY ALA SEQRES 11 B 361 MET ASP LYS ARG VAL SER GLU GLU GLY MET LYS VAL SER SEQRES 12 B 361 CYS THR HIS PHE GLN CYS ALA ALA GLY ALA PHE ALA TYR SEQRES 13 B 361 LEU ARG GLU HIS PHE PRO GLN ALA TYR SER VAL ASP MET SEQRES 14 B 361 SER ARG GLN ILE LEU THR LEU ASN VAL ASN LEU MET LEU SEQRES 15 B 361 GLY GLN ALA GLN GLU CYS LEU LEU GLU LYS SER MET LEU SEQRES 16 B 361 ASP ASN ARG LYS SER PHE LEU VAL ALA ARG ILE SER ALA SEQRES 17 B 361 GLN VAL VAL ASP TYR TYR LYS GLU ALA CYS ARG ALA LEU SEQRES 18 B 361 GLU ASN PRO ASP THR ALA SER LEU LEU GLY ARG ILE GLN SEQRES 19 B 361 LYS ASP TRP LYS LYS LEU VAL GLN MET LYS ILE TYR TYR SEQRES 20 B 361 PHE ALA ALA VAL ALA HIS LEU HIS MET GLY LYS GLN ALA SEQRES 21 B 361 GLU GLU GLN GLN LYS PHE GLY GLU ARG VAL ALA TYR PHE SEQRES 22 B 361 GLN SER ALA LEU ASP LYS LEU ASN GLU ALA ILE LYS LEU SEQRES 23 B 361 ALA LYS GLY GLN PRO ASP THR VAL GLN ASP ALA LEU ARG SEQRES 24 B 361 PHE THR MET ASP VAL ILE GLY GLY LYS TYR ASN SER ALA SEQRES 25 B 361 LYS LYS ASP ASN ASP PHE ILE TYR HIS GLU ALA VAL PRO SEQRES 26 B 361 ALA LEU ASP THR LEU GLN PRO VAL LYS GLY ALA PRO LEU SEQRES 27 B 361 VAL LYS PRO LEU PRO VAL ASN PRO THR ASP PRO ALA VAL SEQRES 28 B 361 THR GLY PRO ASP ILE PHE ALA LYS LEU VAL SEQRES 1 C 361 MET GLU ALA VAL PRO ARG MET PRO MET ILE TRP LEU ASP SEQRES 2 C 361 LEU LYS GLU ALA GLY ASP PHE HIS PHE GLN PRO ALA VAL SEQRES 3 C 361 LYS LYS PHE VAL LEU LYS ASN TYR GLY GLU ASN PRO GLU SEQRES 4 C 361 ALA TYR ASN GLU GLU LEU LYS LYS LEU GLU LEU LEU ARG SEQRES 5 C 361 GLN ASN ALA VAL ARG VAL PRO ARG ASP PHE GLU GLY CYS SEQRES 6 C 361 SER VAL LEU ARG LYS TYR LEU GLY GLN LEU HIS TYR LEU SEQRES 7 C 361 GLN SER ARG VAL PRO MET GLY SER GLY GLN GLU ALA ALA SEQRES 8 C 361 VAL PRO VAL THR TRP THR GLU ILE PHE SER GLY LYS SER SEQRES 9 C 361 VAL ALA HIS GLU ASP ILE LYS TYR GLU GLN ALA CYS ILE SEQRES 10 C 361 LEU TYR ASN LEU GLY ALA LEU HIS SER MET LEU GLY ALA SEQRES 11 C 361 MET ASP LYS ARG VAL SER GLU GLU GLY MET LYS VAL SER SEQRES 12 C 361 CYS THR HIS PHE GLN CYS ALA ALA GLY ALA PHE ALA TYR SEQRES 13 C 361 LEU ARG GLU HIS PHE PRO GLN ALA TYR SER VAL ASP MET SEQRES 14 C 361 SER ARG GLN ILE LEU THR LEU ASN VAL ASN LEU MET LEU SEQRES 15 C 361 GLY GLN ALA GLN GLU CYS LEU LEU GLU LYS SER MET LEU SEQRES 16 C 361 ASP ASN ARG LYS SER PHE LEU VAL ALA ARG ILE SER ALA SEQRES 17 C 361 GLN VAL VAL ASP TYR TYR LYS GLU ALA CYS ARG ALA LEU SEQRES 18 C 361 GLU ASN PRO ASP THR ALA SER LEU LEU GLY ARG ILE GLN SEQRES 19 C 361 LYS ASP TRP LYS LYS LEU VAL GLN MET LYS ILE TYR TYR SEQRES 20 C 361 PHE ALA ALA VAL ALA HIS LEU HIS MET GLY LYS GLN ALA SEQRES 21 C 361 GLU GLU GLN GLN LYS PHE GLY GLU ARG VAL ALA TYR PHE SEQRES 22 C 361 GLN SER ALA LEU ASP LYS LEU ASN GLU ALA ILE LYS LEU SEQRES 23 C 361 ALA LYS GLY GLN PRO ASP THR VAL GLN ASP ALA LEU ARG SEQRES 24 C 361 PHE THR MET ASP VAL ILE GLY GLY LYS TYR ASN SER ALA SEQRES 25 C 361 LYS LYS ASP ASN ASP PHE ILE TYR HIS GLU ALA VAL PRO SEQRES 26 C 361 ALA LEU ASP THR LEU GLN PRO VAL LYS GLY ALA PRO LEU SEQRES 27 C 361 VAL LYS PRO LEU PRO VAL ASN PRO THR ASP PRO ALA VAL SEQRES 28 C 361 THR GLY PRO ASP ILE PHE ALA LYS LEU VAL SEQRES 1 D 361 MET GLU ALA VAL PRO ARG MET PRO MET ILE TRP LEU ASP SEQRES 2 D 361 LEU LYS GLU ALA GLY ASP PHE HIS PHE GLN PRO ALA VAL SEQRES 3 D 361 LYS LYS PHE VAL LEU LYS ASN TYR GLY GLU ASN PRO GLU SEQRES 4 D 361 ALA TYR ASN GLU GLU LEU LYS LYS LEU GLU LEU LEU ARG SEQRES 5 D 361 GLN ASN ALA VAL ARG VAL PRO ARG ASP PHE GLU GLY CYS SEQRES 6 D 361 SER VAL LEU ARG LYS TYR LEU GLY GLN LEU HIS TYR LEU SEQRES 7 D 361 GLN SER ARG VAL PRO MET GLY SER GLY GLN GLU ALA ALA SEQRES 8 D 361 VAL PRO VAL THR TRP THR GLU ILE PHE SER GLY LYS SER SEQRES 9 D 361 VAL ALA HIS GLU ASP ILE LYS TYR GLU GLN ALA CYS ILE SEQRES 10 D 361 LEU TYR ASN LEU GLY ALA LEU HIS SER MET LEU GLY ALA SEQRES 11 D 361 MET ASP LYS ARG VAL SER GLU GLU GLY MET LYS VAL SER SEQRES 12 D 361 CYS THR HIS PHE GLN CYS ALA ALA GLY ALA PHE ALA TYR SEQRES 13 D 361 LEU ARG GLU HIS PHE PRO GLN ALA TYR SER VAL ASP MET SEQRES 14 D 361 SER ARG GLN ILE LEU THR LEU ASN VAL ASN LEU MET LEU SEQRES 15 D 361 GLY GLN ALA GLN GLU CYS LEU LEU GLU LYS SER MET LEU SEQRES 16 D 361 ASP ASN ARG LYS SER PHE LEU VAL ALA ARG ILE SER ALA SEQRES 17 D 361 GLN VAL VAL ASP TYR TYR LYS GLU ALA CYS ARG ALA LEU SEQRES 18 D 361 GLU ASN PRO ASP THR ALA SER LEU LEU GLY ARG ILE GLN SEQRES 19 D 361 LYS ASP TRP LYS LYS LEU VAL GLN MET LYS ILE TYR TYR SEQRES 20 D 361 PHE ALA ALA VAL ALA HIS LEU HIS MET GLY LYS GLN ALA SEQRES 21 D 361 GLU GLU GLN GLN LYS PHE GLY GLU ARG VAL ALA TYR PHE SEQRES 22 D 361 GLN SER ALA LEU ASP LYS LEU ASN GLU ALA ILE LYS LEU SEQRES 23 D 361 ALA LYS GLY GLN PRO ASP THR VAL GLN ASP ALA LEU ARG SEQRES 24 D 361 PHE THR MET ASP VAL ILE GLY GLY LYS TYR ASN SER ALA SEQRES 25 D 361 LYS LYS ASP ASN ASP PHE ILE TYR HIS GLU ALA VAL PRO SEQRES 26 D 361 ALA LEU ASP THR LEU GLN PRO VAL LYS GLY ALA PRO LEU SEQRES 27 D 361 VAL LYS PRO LEU PRO VAL ASN PRO THR ASP PRO ALA VAL SEQRES 28 D 361 THR GLY PRO ASP ILE PHE ALA LYS LEU VAL FORMUL 5 HOH *44(H2 O) HELIX 1 AA1 PHE A 22 ASN A 33 1 12 HELIX 2 AA2 ASN A 37 ALA A 40 5 4 HELIX 3 AA3 TYR A 41 VAL A 56 1 16 HELIX 4 AA4 ASP A 61 SER A 80 1 20 HELIX 5 AA5 ASP A 109 ASP A 132 1 24 HELIX 6 AA6 SER A 136 PHE A 161 1 26 HELIX 7 AA7 SER A 166 MET A 169 5 4 HELIX 8 AA8 SER A 170 ASP A 196 1 27 HELIX 9 AA9 LYS A 199 GLU A 222 1 24 HELIX 10 AB1 ASN A 223 GLY A 231 1 9 HELIX 11 AB2 GLY A 231 GLN A 263 1 33 HELIX 12 AB3 LYS A 265 ALA A 287 1 23 HELIX 13 AB4 PRO A 291 ILE A 319 1 29 HELIX 14 AB5 ALA A 326 LEU A 330 5 5 HELIX 15 AB6 ASP A 348 GLY A 353 1 6 HELIX 16 AB7 PHE B 22 ASN B 33 1 12 HELIX 17 AB8 ASN B 37 ALA B 40 5 4 HELIX 18 AB9 TYR B 41 VAL B 56 1 16 HELIX 19 AC1 ASP B 61 SER B 80 1 20 HELIX 20 AC2 ASP B 109 ASP B 132 1 24 HELIX 21 AC3 SER B 136 PHE B 161 1 26 HELIX 22 AC4 SER B 166 MET B 169 5 4 HELIX 23 AC5 SER B 170 ASP B 196 1 27 HELIX 24 AC6 LYS B 199 GLU B 222 1 24 HELIX 25 AC7 ASN B 223 GLY B 231 1 9 HELIX 26 AC8 GLY B 231 GLN B 263 1 33 HELIX 27 AC9 LYS B 265 ALA B 287 1 23 HELIX 28 AD1 PRO B 291 ILE B 319 1 29 HELIX 29 AD2 ALA B 326 LEU B 330 5 5 HELIX 30 AD3 ASP B 348 GLY B 353 1 6 HELIX 31 AD4 PHE C 22 ASN C 33 1 12 HELIX 32 AD5 ASN C 37 ALA C 40 5 4 HELIX 33 AD6 TYR C 41 VAL C 56 1 16 HELIX 34 AD7 ASP C 61 SER C 80 1 20 HELIX 35 AD8 ASP C 109 ASP C 132 1 24 HELIX 36 AD9 SER C 136 PHE C 161 1 26 HELIX 37 AE1 SER C 166 MET C 169 5 4 HELIX 38 AE2 SER C 170 ASP C 196 1 27 HELIX 39 AE3 LYS C 199 GLU C 222 1 24 HELIX 40 AE4 ASN C 223 GLY C 231 1 9 HELIX 41 AE5 GLY C 231 GLN C 263 1 33 HELIX 42 AE6 LYS C 265 LEU C 286 1 22 HELIX 43 AE7 PRO C 291 ILE C 319 1 29 HELIX 44 AE8 ALA C 326 LEU C 330 5 5 HELIX 45 AE9 ASP C 348 GLY C 353 1 6 HELIX 46 AF1 PHE D 22 ASN D 33 1 12 HELIX 47 AF2 ASN D 37 TYR D 41 5 5 HELIX 48 AF3 GLU D 43 VAL D 56 1 14 HELIX 49 AF4 ASP D 61 SER D 80 1 20 HELIX 50 AF5 ASP D 109 ASP D 132 1 24 HELIX 51 AF6 SER D 136 HIS D 160 1 25 HELIX 52 AF7 SER D 166 MET D 169 5 4 HELIX 53 AF8 SER D 170 ASP D 196 1 27 HELIX 54 AF9 LYS D 199 GLU D 222 1 24 HELIX 55 AG1 ASN D 223 GLY D 231 1 9 HELIX 56 AG2 GLY D 231 GLN D 263 1 33 HELIX 57 AG3 LYS D 265 ALA D 287 1 23 HELIX 58 AG4 PRO D 291 ILE D 319 1 29 HELIX 59 AG5 ALA D 326 LEU D 330 5 5 HELIX 60 AG6 ASP D 348 GLY D 353 1 6 SHEET 1 AA1 3 GLU A 16 PHE A 20 0 SHEET 2 AA1 3 VAL A 94 THR A 97 -1 O THR A 97 N GLU A 16 SHEET 3 AA1 3 SER A 104 HIS A 107 -1 O VAL A 105 N TRP A 96 SHEET 1 AA2 3 ALA B 17 PHE B 20 0 SHEET 2 AA2 3 VAL B 94 THR B 97 -1 O THR B 95 N GLY B 18 SHEET 3 AA2 3 SER B 104 HIS B 107 -1 O VAL B 105 N TRP B 96 SHEET 1 AA3 3 ALA C 17 PHE C 20 0 SHEET 2 AA3 3 VAL C 94 THR C 97 -1 O THR C 95 N GLY C 18 SHEET 3 AA3 3 SER C 104 HIS C 107 -1 O VAL C 105 N TRP C 96 SHEET 1 AA4 3 ALA D 17 PHE D 20 0 SHEET 2 AA4 3 VAL D 94 THR D 97 -1 O THR D 95 N GLY D 18 SHEET 3 AA4 3 SER D 104 HIS D 107 -1 O VAL D 105 N TRP D 96 CRYST1 64.990 66.874 82.424 89.95 89.94 89.84 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015387 -0.000042 -0.000016 0.00000 SCALE2 0.000000 0.014954 -0.000013 0.00000 SCALE3 0.000000 0.000000 0.012132 0.00000